Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.97 SEK -5.52%
Market Cap: 558.9m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Moberg Pharma AB (publ)
Cash Equivalents Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Cash Equivalents
kr60.6m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash Equivalents
kr2.6B
CAGR 3-Years
83%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash Equivalents
kr170m
CAGR 3-Years
-49%
CAGR 5-Years
34%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Cash Equivalents
kr111.3m
CAGR 3-Years
-26%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash Equivalents
kr882.2m
CAGR 3-Years
23%
CAGR 5-Years
77%
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Cash Equivalents?
Cash Equivalents
60.6m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Cash Equivalents amounts to 60.6m SEK.

What is Moberg Pharma AB (publ)'s Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
46%

Over the last year, the Cash Equivalents growth was -52%. The average annual Cash Equivalents growth rates for Moberg Pharma AB (publ) have been 46% over the past three years .

Back to Top